These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799 [TBL] [Abstract][Full Text] [Related]
10. Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD). Thomas SP; Nandhra HS; Jayaraman A J Ment Health; 2010 Apr; 19(2):168-75. PubMed ID: 20433324 [TBL] [Abstract][Full Text] [Related]
11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
12. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Alevizos B; Alevizos E; Leonardou A; Zervas I Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912 [TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633 [TBL] [Abstract][Full Text] [Related]
14. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S; J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127 [TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J; J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976 [TBL] [Abstract][Full Text] [Related]
16. An open study of lamotrigine in refractory bipolar depression. Kusumakar V; Yatham LN Psychiatry Res; 1997 Sep; 72(2):145-8. PubMed ID: 9335206 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review. Shon SH; Joo Y; Lee JS; Kim HW J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):285-7. PubMed ID: 24813210 [TBL] [Abstract][Full Text] [Related]
19. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial. Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473 [TBL] [Abstract][Full Text] [Related]
20. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS; Ng F; Berk M Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]